The complexity of Raf-1 regulation

Current Opinion in Cell Biology

Volumn 9, Issue 2, 1997, Pages 174-179

  Morrison, Deborah K ^a   Cutler Jr , Richard E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RAS PROTEIN;

BINDING SITE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0030898415     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(97)80060-9     Document Type: Article

References (62)

1. Avruch J, Zhang X, Kyriakis JM: Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 1994, 19:279-283.
2. Daum G, Eisenmann-Tappe I, Fries H, Troppmair J, Rapp UR: The ins and outs of Raf kinases. Trends Biochem Sci 1994, 19:474-479.
3. Heidecker G, Huleihel M, Cleveland JL, Kolch W, Beck TW, Lloyd P, Pawson T, Rapp UR: Mutational activation of c-raf-1 and definition of the minimal transforming sequence. Mol Cell Biol 1990, 10:2503-2512.
4. Stanton VP Jr, Nichols DW, Laudano AP, Cooper GM: Definition of the human raf amino-terminal regulatory region by deletion mutagenesis. Mol Cell Biol 1989, 9:639-647.
5. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF: Activation of Raf as a result of recruitment to the plasma membrane. Science 1994, 26:1463-1467.
6. Leevers SJ, Paterson HF, Marshall CJ: Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 1994, 9:411-414.
7. Vojitek AB, Hollenberg SM, Cooper JA: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 1993, 74:205-214.
8. Nassar N, Horn G, Herrmann C, Scherer A, McCormick F, Wittinghofer A: The 2.2 Ȧ crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 1995, 375:554-560. This paper reports the crystal structure of the Raf-1 RBD complexed to the effector domain of the Ras subfamily member Rap1A.
9. Gorman C, Skinner RH, Skelly JV, Neidle S, Lowe PN: Equilibrium and kinetic measurements reveal rapidly reversible binding of Ras to Raf. J Biol Chem 1996, 271:6713-6719.
10. Herrmann C, Martin GA, Wittinghofer A: Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem 1995, 270:2901-2905.
11. Herrmann C, Horn G, Spaargaren M, Wittinghofer A: Differential interaction of the Ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J Biol Chem 1996, 271:6794-6800. This paper examines the affinity and specificity of binding between different members of the Ras subfamily and various Ras effectors.
12. Block C, Janknecht R, Herrmann C, Nassar N, Wittinghofer A: Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo. Nat Struct Biol 1996,3:244-251. A quantitative analysis, using mutants of Raf-1 to correlate the affinity of the Ras-Raf-1 interaction in vitro with Raf-1 activity in vivo. This study identifies key residues of Raf-1 that determine the binding affinity of the RBD to the Ras effector domain.
13. Brtva TR, Drugan JK, Ghosh S, Terrell RS, Campbell-Burk S, Bell RM, Der CJ: Two distinct Raf domains mediate interaction with Ras. J Biol Chem 1995, 270:9809-9812.
14. Drugan JK, Khosravi-Far R, White MA, Der CJ, Sung Y, Hwang Y, Campbell S: Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation. J Biol Chem 1996, 271:233-237. See annotation [15••].
15. Hu C, Kariya K, Tamada M, Akasaka K, Shirouzu M, Yokoyama S, Kataoka T: Cysteine-rich region of Raf-1 interacts with activator domain of post-translationally modified Ha-Ras. J Biol Chem 1995, 270:30274-30277. These two papers [14••,15••] demonstrate that Raf-1 contains two distinct Ras-binding domains, each of which recognizes distinct Ras determinants. One domain is the well characterized RBD and the second encompasses the cysteine-rich domain of Raf-1.
16. Mott HR, Carpenter JW, Zhong S, Ghosh S, Bell RM, Campbell SL: The solution structure of the Raf-1 cysteine-rich domain: a novel Ras and phospholipid binding site. Proc Natl Acad Sci USA 1996, 93:8312-8317. This paper presents the NMR-derived solution structure of the Raf-1 CRD. Comparisons are made between the Raf-1 CRD and the related domains of two PKC isoforms.
17. Michaud NR, Fabian JR, Mathes KD, Morrison DK: 14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras-independent manner. Mol Cell Biol 1995, 15:3390-3397. This study demonstrates that Raf-1 serine phosphorylation is required for the interaction with the 14-3-3 protein. Data are also presented that show that Raf-1 proteins that are unable to stably interact with 14-3-3 are activated, implicating a role for 14-3-3 in stabilizing the inactive conformation of Raf-1.
18. Ghosh S, Xiw WQ, Quest AFG, Mabrouk GM, Sturm JC, Bell RM: The cysteine-rich region of Raf-1 kinase contains zinc, translocates to liposomes and is adjacent to a segment that bind GTP-Ras. J Biol Chem 1994, 269:10000-10007.
19. Huwiler A, Brunner J, Hummel R, Vervoordeldonk M, Stabel S, Van Den Bosch H, Pfeilschifter J: Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci USA 1996, 93:6959-6963. This paper reports that ceramide specifically binds to and activates Raf-1. These findings suggest that ceramide may be an authentic lipid activator of Raf-1 in signaling pathways in which ceramide production is induced.
20. Lerner EC, Qian Y, Blaskovich MA, Fossum RD, Vogt A, Sun J, Cox AD, Der CJ, Hamilton AD, Sebti SM: Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J Biol Chem 1995, 270:26802-26806, Using inhibitors of farnesyltransferase, this study shows that Raf-1 bound to unfarnesylated Ras in the cytosol is inactive. This paper, together with [21•], emphasizes the importance of farnesylation to the ability of Ras to activate Raf proteins.
21. Okada T, Masuda T, Shinkai M, Kariya K, Kataoka T: Post-translational modification of H-Ras is reauired for activation of, but not for association with, B-Raf. J Biol Chem 1996, 271:4671-4678. This paper finds that, although unfarnesylated Ras can bind B-Raf, only farnesylated Ras can activate B-Raf in an in vitro activation system. See also [120•].
22. Clark GJ, Drugan JK, Terrell RS, Bradham C, Der CJ, Bell RM, Campbell S: Peptides containing a consensus Ras binding sequence from Raf-1 and the GTPase activating protein NF1 inhibit Ras function. Proc Natl Acad Sci USA 1996, 93:1577-1581.
23. Van Aelst L, Barr M, Marcus S, Polverino A, Wigler M: Complex formation between Ras and Raf and other protein kinases. Proc Natl Acad Sci USA 1993, 90:6213-6217.
24. Catling AD, Schaefffer H, Reuter CWM, Reddy GR, Weber MJ: A proline-rich sequence unique to MEK1 and MEK2 is required for Raf binding and regulates MEK function. Mol Cell Biol 1995, 15:5214-5225. This paper reports that MEK1 and MEK2 contain a unique proline-rich sequence that is required for Raf-1 binding. This sequence may be a recognition motif involved in directing specific MEK-protein interactions.
25. Morrison D: 14-3-3: modulators of signaling proteins? Science 1994, 266:56-57.
26. Irie K, Gotoh Y, Yashar BM, Errede B, Nishida E, Matsumoto K: Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. Science 1994, 265:1716-1719.
27. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT: Activation of Raf-1 by 14-3-3 proteins. Nature 1994, 371:612-613.
28. Freed E, Symons M, Macdonald SG, McCormick F, Ruggieri R: Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 1994, 265:1713-1716.
29. Aitken A: 14-3-3 and its possible role in co-ordinating multiple signalling pathways. Trends Cell Biol 1996, 6:341-347. A thorough review examining the function of 14-3-3 in multiple signaling pathways.
30. Muslin AJ, Tanner JW, Allen PM, Shaw AS: Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 1996, 84:889-897. This paper demonstrates that 14-3-3 is a specific phosphoserine-binding protein, and defines a phosphorylation-dependent 14-3-3-binding motif (RSxS*xP [single-letter code for amino acids; x represents any amino acid and S* represents phosphorylated serine]). These findings reveal that serine-phosphorylated residues, like tyrosine-phosphorylated residues, can act as recognition sites for protein interactions.
31. Morrison DK, Heidecker G, Rapp UR, Copeland TD: Identification of the major phosphorylation sites of the Raf-1 kinase. J Biol Chem 1993, 268:17309-17316.
32. Rommel C, Radziwill G, Lovric J, Noeldeke J, Heinicke T, Jones D, Aitken A, Moelling K: Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 1996, 12:609-619.
33. Dent P, Jelinek T, Morrison DK, Weber MJ, Sturgill TW: Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases. Science 1995, 268:1902-1906. This paper reports that activated Raf-1 can be inactivated by both serine/threonine- and tyrosine-specific phosphatases, and that the dephosphorylation and inactivation of Raf-1 can be blocked by the binding of 14-3-3 and hsp90.
34. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A, Gamblin SJ: Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature 1995, 376:188-191. See annotation [35•].
35. Liu D, Bienkowska J, Petoa C, Collier RJ, Fu H, Liddington R: Crystal structure of the zeta isoform of the 14-3-3 protein. Nature 1995, 376:191-194. These two papers [34•,35•] present the crystal structures of two different isoforms of 14-3-3, namely C and T. Both isoforms were able to form dimers, and the residues in the dimer interface were found to be invariant among all 14-3-3 isoforms, indicating the potential for the formation of heterodimers and larger protein complexes.
36. Braselmann S, McCormick F: BCR and RAF form a complex in vivo via 14-3-3 proteins. EMBO J 1995, 14:4839-4848.
37. Conklin DS, Galaktionov K, Beach D: 14-3-3 proteins associate with cdc25 phosphatases. Proc Natl Acad Sci USA 1995, 92:7892-7896.
38. Vincenz C, Dixit V: 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adaptor molecules. J Biol Chem 1996, 271:20029-20034.
39. Aitken A, Jones D, Soneji Y, Howell S: 14-3-3 proteins: biological function and domain structure. Biochem Soc Trans 1995, 23:605-611.
40. Wartmann M, Davis RJ: The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex. J Biol Chem 1994, 269:6695-6701.
41. Stepanova L, Leng X, Parker SB, Harper JW: Mammalian p50 Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev 1996, 10:1491-1502. p50 is identified as the mammalian homolog of cdc37 from Saccharomyces cerevisiae and is reported to be the protein kinase targeting subunit of the molecular chaperone hsp90.
42. Schulte TW, Blagosklonny MV, Ingui C, Neckers L: Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J Biol Chem 1995, 270:24585-24588. See annotation [43•].
43. Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM: Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol Cell Biol 1996, 16:5839-5845. These papers [42•,43•] show that pharmacological disruption of the Raf-1-hsp90 complex destabilizes the endogenous Raf-1 protein and disrupts Raf-1-mediated signal transduction.
44. Therrien M, Michaud NR, Rubin GM, Morrison DK: KSR modulates signal propagation within the MAPK cascade. Genes Dev 1996, 10:2684-2695. This paper examines the function of the mammalian homolog of the Drosophila and Caenorhabditis elegans protein KSR, and finds that KSR facilitates signal transduction between Raf-1, MEK, and MAPK. KSR is also shown to associate with Raf-1 at the membrane in a Ras-dependent manner, indicating the presence of a membrane-bound signaling complex.
45. Farrar MA, Alberola-lla J, Perlmutter RM: Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization. Nature 1996, 383:178-181. See annotation [46•].
46. Luo Z, Tzivion G, Belshaw PJ, Vawas D, Marshall M, Avruch J: Oligomerization activates c-Raf-1 through a Ras-dependent mechanism. Nature 1996, 383:181-185. These two papers [45•,46•] show that Raf-1 can be activated by chemical-induced oligomerization. However, while Farrar et al. [45•] found that the activation of Raf-1 by oligomerization is Ras-independent, Luo et al. [46•] found that an interaction with Ras is required.
47. Hallberg B, Rayter SI, Downward J: Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. J Biol Chem 1994, 269:3913-3916.
48. Fabian JR, Daar IO, Morrison DK: Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol Cell Biol 1993, 13:7170-7179.
49. Marais R, Light Y, Paterson HF, Marshall CJ: Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J 1995, 14:3136-3145. In this paper, the interaction between Ras and Raf-1 in NIH3T3 cells is found to localize Raf-1 to the plasma membrane for activation mediated by oncogenic Src. This Src-mediated activation involves the phosphorylation of tyrosine residues 340 and 341, This paper also shows that Raf-1 is activated by mechanisms other than tyrosine phosphorylation.
50. Popik W, Pitha PM: Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway. Mol Cell Biol 1996, 16:6532-6541.
51. Park RK, Liu Y, Durden DL: A role for Shc, Grb2, and Raf-1 in FcγRI signal relay. J Biol Chem 1996, 271:13342-13348.
52. Kasid U, Suy S, Dent P, Ray S, Whiteside TL, Sturgill TW: Activation of Raf by ionizing radiation. Nature 1996, 382:813-816.
53. Xia K, Mukhopadhyay NK, Inhorn RC, Barber DL, Rose PE, Lee RS, Narsimhan RP, Dandrea AD, Griffin JD, Roberts TM: The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21 ras-dependent manner. Proc Natl Acad Sci USA 1996, 93:11681-11686. This paper couples the cytokine receptor family to the Raf-1/MAPK cascade. Using the baculovirus expression system, this study shows that JAK-2 can associate with and activate Raf-1 in a manner that is Ras-dependent and that may involve the tyrosine phosphorylation of Raf-1.
54. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR: Protein kinase Ca activates Raf-1 by direct phosphorylation. Nature 1993, 364:249-252.
55. Carroll MP, May WS: Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J Biol Chem 1994, 269:1249-1256.
56. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S: Protein kinase C δ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 1996, 271:23512-23519.
57. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R: Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995, 378:307-310.
58. Hafner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W: Mechanism of inhibition of Raf-1 by protein kinase A. Mol Cell Biol 1994, 14:6696-6703.
59. Samuels ML, Weber MJ, Bishop M, McMahon M: Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol Cell Biol 1993, 13:6241-6252.
60. Papin C, Denouel A, Calothy G, Eychene A: Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. Oncogene 1996, 12:2213-2221.
61. Yamamori B, Kuroda S, Shimizu K, Fukui K, Ohtsuka T, Takai Y: Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. J Biol Chem 1995, 270:11723-11726.
62. αi/o subunits. J Biol Chem 1996, 271:3119-3123. This paper is one of the first to address the mechanisms by which Raf-1 activity is downmodulated. A GTP-regulated protein tyrosine phosphatase that inactivates membrane-associated Raf-1 is characterized.